Mobia Medical Inc 's Quick Ratio

MOBI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

Mobia Medical Inc 's Cash & cash equivalent grew by 217.79 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Mobia Medical Inc 's Quick Ratio to 12.24 a new company high.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Quick Ratio than Mobia Medical Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 330.

Explain Quick Ratio?
How much Cash & cash equivalents MOBI�s has?
What are MOBI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MOBI Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q2	Q1
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	12.24	5.72	3.29	-	-
MOBI's Total Ranking	# 330	# 0	#	#	#
Seq. Current Liabilities Change	48.43 %	-4.47 %	-	-	-
Seq. Cash & cash equivalent Change	217.79 %	65.91 %	-	-	-

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 8
Healthcare Sector	# 130
Overall Market	# 330

Quick Ratio Statistics
High	Average	Low
12.24	6.75	3.29
(Jun 30 2026)		(Dec 31 2025)

Financial Statements
Mobia Medical Inc 's Current Liabilities	$ 14 Millions	Visit MOBI's Balance sheet
Mobia Medical Inc 's Cash & cash equivalent	$ 177 Millions	Visit MOBI's Balance sheet
Source of MOBI's Sales		Visit MOBI's Sales by Geography

Cumulative Mobia Medical Inc 's Quick Ratio

MOBI's Quick Ratio for the trailling 12 Months

MOBI Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	7.74	4.48	3.29	-	-
Total Ranking TTM	#	#	#
Seq. Current Liabilities TTM Growth	72.52 %	95.53 %	-	-	-
Seq. Cash & cash equivalent TTM Growth	198.28 %	165.91 %	-	-	-

Quick ratio ranking by company, industry and sector >> Back to MOBI Financial Strength Comparisons >> Go to Compare MOBI Quick Ratio to its Competitors

On the trailing twelve months basis MOBI Cash & cash equivalent more than doubled by 217.79 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Mobia Medical Inc 's Quick Ratio to 7.74, above MOBI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 7 other companies have achieved higher Quick Ratio than Mobia Medical Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents MOBI�s has?
What are MOBI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 8
Healthcare Sector	# 130
Within the Market	# 330

trailing twelve months Quick Ratio Statistics
High	Average	Low
12.24	6.75	3.29
(Jun 30 2026)		(Dec 31 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Global Innovative Platforms Inc.	31.35	$ 0.244 Millions	$ 0.008 Millions
Anteris Technologies Global Corp	14.02	$ 257.385 Millions	$ 18.360 Millions
Heartflow Inc	13.95	$ 615.238 Millions	$ 44.088 Millions
Ceribell Inc	13.13	$ 225.898 Millions	$ 17.200 Millions
Perspective Therapeutics Inc	12.80	$ 467.708 Millions	$ 36.544 Millions
Lemaitre Vascular Inc	12.57	$ 376.240 Millions	$ 29.935 Millions
Mobia Medical Inc	12.24	$ 177.090 Millions	$ 14.472 Millions
Envveno Medical Corporation	11.39	$ 21.486 Millions	$ 1.887 Millions
Pulse Biosciences Inc	9.26	$ 101.620 Millions	$ 10.978 Millions
Orchestra Biomed Holdings Inc	8.16	$ 109.963 Millions	$ 13.471 Millions
Biolife Solutions Inc	8.11	$ 113.100 Millions	$ 13.947 Millions
Bone Biologics Corporation	7.87	$ 4.032 Millions	$ 0.512 Millions
Beyond Air Inc	7.68	$ 26.340 Millions	$ 3.428 Millions
Talkspace Inc	7.62	$ 90.998 Millions	$ 11.937 Millions
Safe Pro Group Inc	7.24	$ 10.231 Millions	$ 1.413 Millions
Delcath Systems Inc	7.22	$ 95.902 Millions	$ 13.279 Millions
Streamex Corp	7.16	$ 18.586 Millions	$ 2.595 Millions
Endra Life Sciences Inc	7.04	$ 5.540 Millions	$ 0.787 Millions
Iradimed Corporation	6.45	$ 59.080 Millions	$ 9.164 Millions
Orasure Technologies Inc	6.39	$ 160.582 Millions	$ 25.119 Millions
Alpha Pro Tech Ltd	5.94	$ 18.901 Millions	$ 3.180 Millions
Si bone inc	5.89	$ 141.519 Millions	$ 24.042 Millions
Dexcom Inc	5.84	$ 1,107.000 Millions	$ 189.500 Millions
Cvrx inc	5.78	$ 64.586 Millions	$ 11.177 Millions
Carlsmed Inc	5.67	$ 70.244 Millions	$ 12.397 Millions
Profound Medical Corp	5.24	$ 38.271 Millions	$ 7.304 Millions
Rxsight Inc	5.03	$ 404.247 Millions	$ 80.444 Millions
Transmedics Group Inc	4.81	$ 472.675 Millions	$ 98.283 Millions
Aethlon Medical Inc	4.76	$ 4.934 Millions	$ 1.036 Millions
Bluejay Diagnostics Inc	4.53	$ 9.599 Millions	$ 2.117 Millions

Date modified: 2026-09-05T00:12:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.